Get complete access to comprehensive company data for Naari Pharma Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Naari Pharma Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 86.83 cr
₹ 2.70 cr
23 Feb 1978
31 Mar 2024
Naari Pharma Private Limited is an Indian private limited company incorporated on 23 Feb 1978. The company's registered office is situated in Bangaluru, Karnataka, India.
The current status of Naari Pharma Private Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2024 (FY 2023-2024).
Naari Pharma Private Limited is a company limited by shares with an authorized capital of ₹86.83 cr and a paid-up capital of ₹2.70 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Naari Pharma Private Limited has 4 directors and 1 signatories. The Key Managerial Personnel (KMP) at Naari Pharma Private Limited include Prashanth Bhaskar as CFO. The directors of the company include Chandrappa Seetharamaiah, Prithipal Singh Kochhar, Deepak Komaregowda, Hermann Osterwald.
The registered office of Naari Pharma Private Limited is located at Plot No.30, Galaxy, 1St Main Road Jp Nagar, Third Phase Bangalore Karnataka 560078 India in Bangaluru, Karnataka, India.
- CIN/LLPIN/FCRN: U74899KA1978PTC142872
- Legal Name: Naari Pharma Private Limited
- ROC Code: Roc Bangalore
- Company No.: 008881
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Private
- Listing Status: Unlisted
- Industry: -
- Date of AGM: 28 Sep 2024
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Naari Pharma Private Limited |
|---|
Frequently Asked Questions
- chandrappa seetharamaiah
- deepak komaregowda
- hermann osterwald
- prashanth bhaskar
- prithipal singh kochhar